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Abstract
Background This study was aimed at the evaluation of the
relationship between genetic polymorphisms of catechol-O-
methyltransferase (COMT) (rs4680:A > G—Val158Met,
rs6269:A > G, rs4633:C > T, rs4818:C > G) and pain sensi-
tivity after lumbar discectomy.
Methods All patients had one-level symptomatic disc hernia-
tion from L3 to S1. The primary data recorded included visual
analogue pain scales assessing back and leg pain, Oswestry
Disability Questionnaire assessing quality of life and pain
intensity, received/filled pre- and postoperatively. Each sub-
ject was genotyped for single-nucleotide polymorphism in the
COMT gene. Clinical outcome was measured by difference
between pre- and postoperative values and those results were
analyzed with genetics findings.
Results Pain intensity was associated with the COMT poly-
morphism. Carriers of rs6269 AA , rs4633 TT, rs4818 CC , and
rs4680 AA genotypes were characterized by the lowest preop-
erative scores related to pain intensity and lower pain intensity
at 1 year after the surgery. The rs4633 CC , rs4680 GG geno-
types demonstrated significant clinical improvement in
VASBACK score at 1 year after the surgery. Patients with
COMT haplotype associated with low metabolic activity of
enzyme (A_C_C_G) showed better clinical outcomemeasured
by ODI score and VASBACK score 1 year after surgery. We did
not observe any significant correlation between leg pain and
single-nucleotide polymorphisms in the COMT gene.
Conclusions The results of our study indicate that polymor-
phism in the COMT gene may play an important role in the
mechanism of pain perception, which may have a potential
implication for clinical decision-making in the future.
Keywords COMT . Lumbar discectomy . Clinical outcome .
Genetic variations . Lumbar disk herniation . Pain
Introduction
Disc herniation is a classic cause of spinal and radicular pain.
Isolated lower back pain is a common symptom and has been
estimated to affect up to 80 % of individuals at any time of
their lives [2]. In 98 % of cases, lower back pain is thought to
be caused by degenerative changes in the lumbar spine,
whereas the remaining 2 % of cases are attributed to other
disorders. However, there is no clear relationship between
clinical symptoms and radiological findings [14, 22, 28].
Lumbar discectomy is commonly offered for treatment of
sciatica due to disc herniation. However, literature reports on
resolving back pain are non-conclusive, i.e., some results
show significant improvement in reducing back pain [3, 11,
25, 29], whereas other papers present contradictory observa-
tions [4, 30].
One of the potential factors affecting pain perception is
genetic diversity [19]. Polymorphisms in the coding regions of
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the COMT gene result in altered enzymatic activity, and
entails different pain-associated catecholamine and
encephalin levels [20]. Studies show that reduced COMT
activity results in increased pain sensitivity in animal models
and in humans [8, 20]. Clinical studies demonstrate also less
prominent facial pain in patients characterized by lower
COMT activity [16]. Similarly, some studies reported that
polymorphisms of the COMT gene resulting in reduced en-
zyme activity were associated with fibromyalgia [10], tempo-
romandibular disorder [8, 20], and affected morphine efficacy.
Dai et al. [7] postulated in their study of patients subjected to
degenerative disc disease that genetic variation in the COMT
gene might be one of the factors associated with pain sensi-
tivity. The authors were able to reveal a borderline association
(not statistically significant) between certain COMT haplo-
types and pain intensity measured by VAS score after surgery.
Since there is no clear statement on the role of COMT
polymorphism in pain perception in subjects after lumbar
spine surgery, the present study was designed. It is aimed at
the search for an association between COMT SNPs (single-
nucleotide polymorphism) and haplotypes and pain sensitivity
in patients with a history of leg and back pain, diagnosed with
lumbar disc herniation (LDH), who subsequently underwent
lumbar discectomy.
Materials and methods
A total of 176 patients of Caucasian origin diagnosed with
lumbar disc herniation and subjected to lumbar discectomy
were recruited for the prospective study carried out at the
Neurosurgery Department of Medical University of Gdansk,
Poland, in 2009–2010. The main inclusion criterion was per-
sistent back and leg pain resistant to conservative therapy for
at least 6 months with lumbar disc herniation on CT or MRI
scans. Surgery was performed on one of the levels from L3 to
S1 by one of four neurosurgeons. The same midline standard
posterior approach was used with the assistance of an intra-
operative microscope. Exclusion criteria included: patients
receiving narcotic pain medications, patients who had pro-
gression of symptoms and required immediate surgery, re-
operation, fixed motor deficit, spinal stenosis, cauda equina
syndrome, and spine deformities. Patients diagnosed with
conditions which could influence their perception of pain, like
mental disorder (depression) or polyneuropathy, were not
eligible for this study. Any other comorbidities were not
analyzed.
Patient clinical status was recorded by means of self-
reported questionnaires: (Oswestry Disability Index (ODI)
and visual analogue pain scale (VAS) separately for lower
back pain—VASBACK, and leg pain—VASLEG), all completed
before surgery and 12months post-operatively with the aim to
concentrate on chronic pain. For the purpose of this study, the
first question fromODI was extracted. The study protocol was
approved by the local ethics committee, and each patient
signed informed consent forms.
Genotyping
SNPs within the COMT gene were evaluated using Taqman
genotyping assays. Genomic DNAwas extracted from 200 μl
of whole blood samples using GeneMATRIX Quick Blood
DNA Purification Kit (EURx, Poland). Pre-validated allelic
discrimination TaqMan real-time PCR assays were used for
detection of rs6269:G > A, rs4633:C > T, rs4818:C > G, and
rs4680:G > A SNPs (respective assay IDs: C___2538746_1,
C _ _ _ 2 5 3 8 7 4 7 _ 2 0 , C _ _ _ 2 5 3 8 7 5 0 _ 1 0 , a n d
C__25746809_50) (Applied Biosystems, California, USA).
Fluorescence data was captured using 7500 FAST Real-
Time PCR System (Applied Biosystems), after 40 cycles of
PCR. Haplotypes were classified in according to COMT
activity, A_C_C_G – low, A_T_C_A – medium and
G_C_G_G – high activity. Diplotype was assigned to each
patient and data were further analyzed.
Statistical analysis
Associations between categorical variables were assessed by
Chi-square test. Analysis of associations between COMT
genotypes and clinical parameters was performed by means
of Mann–Whitney U test. General linear model was used for
multivariate analysis. A p value of less than 0.05 was consid-
ered statistically significant. Calculations were performed
using the Statistica 7.1 software package (StatSoft, Oklahoma,
USA). The EH program (Rockefeller University) was used to
estimate haplotype frequencies.
Results
The data from 176 patients, 73 females (41.5%) and 103males
(58.5%), aged 20 to 80 years (mean age, 46.7±13.2 years) was
collected. Distribution of COMT SNPs rs6269:A > G,
rs4633:C > T, rs4818:C > G and rs4680:A > G were in
agreement with Hardy-Weinberg equilibrium (p >0.7). The
frequencies of COMT “low” A_C_C_G, “medium”
A_T_C_A and “high” G_C_G_G activity haplotypes were
calculated (Fig. 1). Themost commonCOMT haplotypeswere
these of “medium” (49.1 %) and “high” (39.5 %) activity, the
“low” activity haplotype A_C_C_G was found in 11.1 % of
patients. No associations between COMT genotypes or haplo-
types with gender were found.
Homozygous COMT rs6269 AA patients demonstrated a
trend towards lower pain intensity preoperatively (pain inten-
sity in Oswestry score) (p =0.056) as well as lower pain
intensity at 1 year after the surgery p =0.091 in comparison
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with G allele carries. Significantly lower postoperative pain
intensity was experienced by rs6269G subjects (p =0.02GG +
GA vs.AA). Patients whowere homozygous forCOMT rs6269
A demonstrated also a significantly lower preoperative back
pain VASBACK (p =0.045) compared with the GG genotype
subjects. Non-significant trend was observed for VASBACK
improvement in GG subjects in comparison with other geno-
types (p =0.053) (Tables 1 and 2).
Statistical analysis of COMT rs4633 polymorphism point
out significantly lower pain intensity in both pre- (p =0.044)
and postoperative (p =0.010) period in TT genotype carriers
vs. TC + CC genotypes. In homozygous CC patients, higher
scores in VASBACK scale before surgery were recorded. Sig-
nificantly higher VASBACK improvement in CC carriers in
comparison with other genotypes (p =0.0042) was noted. No
association between SNP COMT rs4818 and improvement in
ODI or VAS changes was found. However, patients with CC
genotype demonstrated significantly lower pain intensity in
postoperative ODI (p =0.031). Additionally, carriers of CC
genotype showed significantly higher preoperative VASBACK
score compared with GC + GG patients. CC subjects tended
to have better clinical outcome one year after surgery (p =
0.055) (Tables 1 and 2). Association of COMT rs4680 poly-
morphism with ODI and VAS scores is presented in Table 1
with p values shown in Table 2. Carriers of AA genotype
presented lower pain intensity in ODI pre- (p =0.048) and
postoperatively (p =0.018), though improvement rate was
not significant (p =0.59). In patients with GG genotype, a
trend towards higher preoperative pain intensity in ODI and
significantly better clinical outcome recorded in VASBACK
score in comparison with other genotypes were observed
(p =0.0042) (Fig. 2).
The carrier status of at least one copy of COMT A_C_C_G
haplotype determines low metabolic activity of COMT en-
zyme, and patients with at least one copy of A_C_C_G
haplotype show better clinical outcome measured by ODI
score, compared with non-carriers, who inherited a combina-
tion of G_C_G_G, A_T_C_A or A_T_G_G haplotypes (i.e.,
subjects without A_C_C_G haplotype), although the recorded
Fig. 1 Illustration of incidence of different SNPs, depicted on the right
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improvement in ODI score was only borderline significant
(p =0.079, Table 3). However, the effect of A_C_C_G haplo-
type was reflected by the improvement in VASBACK score as
compared with non-carriers (p =0.017). Because of the pres-
ence of COMT G_C_G_G (high activity) haplotype is equiv-
alent to the presence of rs6269 G allele and the presence of
A_T_C_A (medium) haplotype is equivalent to the presence
of rs4680 A allele, associations of these haplotypes with the
evaluated parameters are equal to the respective genotypes.
However, haplotype “low” is not equivalent to the presence of
any of the studied genotypes (the respective results are pre-
sented in Table 3).
Multivariate general linear models adjusted for patients’
age and gender and COMT genotypes (Table 4) showed that
the presence of at least one copy of rs4633 T or rs4626A allele
or COMT L A_C_C_G haplotype (due to a strong linkage
disequilibrium, these variables could not be analyzed in one
model) are independent predictors of better clinical response
(by 1.2 and 1.45 in VASBACK, p =0.0032 and p =0.046,
respectively). Haplotype “low” activity was also markedly,
but statistically insignificantly, associated with clinical im-
provement in ODI (by 4.1, p =0.051).
Discussion
In spite of recent advances in surgical technique, effective pain
treatment in patients suffering from lumbar spine pathology
still remains a considerable clinical problem. Surgical inter-
vention criteria in those patients are clear-cut in case of cauda
equina syndrome or progressive motor deficit, but elective
surgery is based on individual decision [6, 13, 23, 26, 27].
The latter approach is partly caused by the use of various pain-
assessment tools, and even those considered as a “gold stan-
dard” in evaluation of surgery results still lack validation [6].
Problems with decision-making in patient classification for
surgery or conservative treatment may also result from inter-
individual differences in pain threshold that may be deter-
mined at least partly by genotype.
The first direct evidence that COMT polymorphism affects
neural processing of pain was reported by Zubieta et al. [31],
who noted that COMT 158met (rs4680) homozygotes were
characterized by higher pain sensitivity, diminished regional μ-
opioid system responses to pain, as well as a higher μ-opioid
receptor binding potential, in comparison with heterozygotes
and 158 val homozygotes. Additionally, Loggia et al. [15]
provided information on COMT val158met polymorphism
involvement in pain perception in response to heat stimuli.
The authors found that met/met subjects exhibited stronger
pain-related fMRI signals than val/val in several brain struc-
tures. Therefore, met/met patients might be characterized by
lower pain threshold and higher risk of chronic pain develop-
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lumbar pain did not support the aforementioned reports, since
no significant associations between COMT val158met poly-
morphism and VAS/ODI score have been found, except for
better response to treatment in GG (val/val) cases.
However, analyzing solely pre- and postoperative pain
intensity it can be seen, that AA subjects were characterized
by markedly lower pain intensity measures vs. G allele car-
riers. Contribution of other COMT genotypes to pain
Fig. 2 a–d Plots of changes in different pain scales after surgery and 1-year follow-up, grouped by distinct genotypes. Asterisk (*) depicts differences
with p <0,05. (A)—denotes minor allele, (B)—major allele
Table 3 Patients’ clinical evalu-
ation in patients classified based
on the presence of COMT
A_C_C_G haplotype, determin-
ing low enzyme activity
Significance for bold numbers in
all the text (including tables) is
p <0.05
Haplotype L (A_C_C_G) Present vs. absent
Absent (n=138) Present (n =38) p value
Preoperative ODI 25.79±9.49 27.68±8.82 0.27
Postoperative ODI 17.36±10.69 15.42±10.20 0.28
ODI change −8.42±11.6 −12.26±10.44 0.079
Preoperative VAS BACK 6.68±2.73 6.89±2.42 0.81
Postoperative VAS BACK 4.65±2.8 3.65±2.97 0.052
VAS BACK change −2.08±2.78 −3.23±3.12 0.017
Preoperative VAS LEG 7.01±2.65 7.06±2.23 0.77
Postoperative VAS LEG 3.97±3.17 4.07±3.2 0.92
VAS LEG change −3.04±3.56 −3.03±3.73 0.98
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perception does also support a modulatory effect of these
genetic parameters. Significantly lower preoperative pain in-
tensity was experienced by 4633 TT, 4680 AA and higher in
4818 GG subjects, whereas postoperative pain intensity was
markedly decreased in 4633 TT, 4818CC , 4680 AA and 6269
AA carriers. Also, local pain perception in LDH patients was
associated with COMT polymorphism, and preoperative
VASBACK was the most prominent in patients characterized
by 6269 GG and 4818 CC genotypes. Likewise, COMT
polymorphism significantly modulated response to surgery
(VASBACK change), i.e., the best outcomes were observed in
6269 CC , 4633 CC , and 4680 GG carriers. These observa-
tions are supported by linear regression analysis, which dem-
onstrated that COMT rs4633 T allele and rs4680 A allele are
independent risk factors for VASBACK change (Table 4). The
observed differences in pain perception in patients of various
genetic constitutions may enable identification of subjects
particularly predisposed to chronic pain development, and
thus requiring more intensive analgesic treatment. Our find-
ings are in agreement with the report by Jacobsen et al. [12],
who revealed that COMT val158met polymorphism could
contribute to discogenic subacute low back pain and sciatica
in degenerative disc disease, since val/val patients (like in the
present study) were characterized by the largest reduction in
postoperative pain in comparison with met/val and met/met
carriers. Associations between COMT gene SNPs and pain
were also evaluated by Dai et al. [7], using ODI and VAS, in a
group of patients subjected to surgical treatment for LDH. The
authors reported that patients homozygous for COMT rs4633 T
allele were characterized bymost prominent mean improvement
in ODI score one year after surgery, which was not observed in
our study (response measured by ODI change was similar in all
rs4633 genotypes). Contrary to the present results Dai et al. [7]
did not reveal significant impact of other studied SNPs, i.e.,
rs6269, rs4818 and rs4680 on pain perception.
Recent studies suggest that COMT haplotypes, rather than
individual SNPs, would be more appropriate for the prediction
of COMT biological effects [8, 31]. Even silent mutations that
usually do not change the amino-acid sequence may affect
function through alterations in COMT mRNA structure and
stability, thus influencing disease risk or treatment efficacy.
Diatchenko et al. [8] revealed a strong association between a
specific COMT haplotype - G_C_G_G and pain sensitivity,
and an inverse correlation between pain sensitivity and COMT
activity in healthy subjects. Low sensitivity to experimental
pain was associated with G_C_G_G haplotype (high activity
haplotype), whereas A_C_C_G haplotype (low activity) was
associatedwith high pain sensitivity. Dai et al. [7] also reported
that COMT haplotype status was associated with pain percep-
tion in patients undergoing surgical treatment for lumbar de-
generative disc disease. Patients with A_T_C_A haplotype
responded most effectively to the surgical procedure, and were
followed by subjects carrying G_C_G_G haplotype and
A_C_C_G, haplotype, as measured by ODI score. Our find-
ings are contrary to observations of Dai et al., who found that
A_C_C_G haplotype patient were characterized by signifi-
cantly higher postoperative VASBACK pain, and responded less
effectively to treatment (VASBACK change). Likewise, linear
regression analysis applied in the present study indicated that
COMT A_C_C_G haplotype was an independent risk factor
for VASBACK and possibly ODI changes (Table 3). Recently, a
study of McLean et al. [17] has confirmed the opinion that
individuals with COMT pain vulnerable genotype A_C_C_G
were at increased risk of acute pain and needed preventive
interventions. The authors evaluated an association between
COMT genotype and acute neck pain intensity in individuals
after motor vehicle collision, and found that individuals char-
acterized by COMT A_C_C_G haplotype were more likely to
report moderate-to-severe neck pain, headache, and dizziness.
Moreover, patients with genotype coding low COMT enzyme
activity were found to have longer time to physical and emo-
tional recovery. Likewise, Tchivileva et al. [24], studying an
association between commonCOMT haplotypes and response
to β-blocker treatment in a common chronic musculoskeletal
pain disorder, found that carriers of low and medium COMT
activity haplotype showed the most prominent response to
propranolol in all pain measures except for thermal threshold.
Patients carrying COMT A_C_C_G haplotype demonstrated
not only more efficient response to pharmacological treatment
but also better surgical treatment outcome.
Table 4 General linear regression models of factors potentially associ-
ated with back pain intensity
Independent variables VASBACK change p value
Regression coefficient
Age 0.014 0.38
Male sex 0.59 0.17
Presence of rs4633 allele T −1.45 0.0032
Independent variables VASBACK change p value
Regression coefficient
Age 0.012 0.44
Male sex 0.53 0.22
Presence of rs4680 allele A −1.2 0.046
Independent variables VASBACK change p value
Regression coefficient
Age 0.01 0.47
Male sex 0.66 0.13
Presence of COMT haplotype L −1.3 0.014
Independent variables ODI change p value
Regression coefficient
Age 0.009 0.89
Male sex 2.36 0.18
Presence of COMT haplotype L −4.14 0.051
Significance for bold numbers in all the text (including tables) is
p <0.05
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Pain analysis is problematic due to its subjective nature and
broad range of factors modulating it, such as ethnicity as
evidenced by known differences in both pain perception and
reporting between African Americans and Caucasians [5, 9].
This may be related to COMT rs4680 158met frequency in
various populations, ranging from 0.01 to 0.62 [21]. This fact
creates difficulties in developing reliable scales characterizing
pain. As Polish population in 98 % consists in Caucasian and
additionally ethnic differences in catechol-O -methyltransfer-
ase activity is confirmed [1, 18] we found it reasonable to
focus only on one ethnic group. Undoubtedly, to confirm our
results, further studies in Asian or African American popula-
tions should be designed.
In conclusion, the aim of this study was to find a potential
correlation between genetic polymorphism of the COMT
enzyme and pain perception. This association was observed
in patients with the COMT SNP rs4633 CC , rs4680 GG, who
demonstrated greater reduction of low back pain in 1 year after
surgery. This fact may have potential clinical implication in
decision-making, e.g., selection of those subjects for earlier
surgery. We believe that the lack of correlation between
COMT activity and reduction of leg pain (VASLEG) after
surgery can be explained by the pivotal role of direct nerve
root decompression during surgery. As for the present study,
the studied group of patients is too small to draw arbitrary
conclusions regarding genetic diversity in COMT and its role
in predicting clinical outcome after lumbar discectomy. The
observed associations suggest that it is not possible to make a
clinical decision on operation or conservative treatment based
solely on the COMT gene polymorphism. However, the
COMT genotype may serve as a tool indicating patients who
will benefit more from surgery, being one of the factors behind
decision-making, along with other parameters (like radiolog-
ical findings, clinical status); to some extent, pharmacogenet-
ics may play a supportive role as a prognostic factor. However,
given a relatively small group size, larger studies are needed in
order to confirm the value of the present study observations.
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